These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 12099891
21. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding. Alexacou KM, Hayes JM, Tiraidis C, Zographos SE, Leonidas DD, Chrysina ED, Archontis G, Oikonomakos NG, Paul JV, Varghese B, Loganathan D. Proteins; 2008 May 15; 71(3):1307-23. PubMed ID: 18041758 [Abstract] [Full Text] [Related]
22. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site. Kristiansen M, Andersen B, Iversen LF, Westergaard N. J Med Chem; 2004 Jul 01; 47(14):3537-45. PubMed ID: 15214781 [Abstract] [Full Text] [Related]
23. Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens. Gibbs ME, Anderson DG, Hertz L. Glia; 2006 Aug 15; 54(3):214-22. PubMed ID: 16819764 [Abstract] [Full Text] [Related]
24. Inhibition of the interaction between protein phosphatase 1 glycogen-targeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes. Zibrova D, Grempler R, Streicher R, Kauschke SG. Biochem J; 2008 Jun 01; 412(2):359-66. PubMed ID: 18298402 [Abstract] [Full Text] [Related]
25. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme. Chen L, Li H, Liu J, Zhang L, Liu H, Jiang H. Bioorg Med Chem; 2007 Nov 01; 15(21):6763-74. PubMed ID: 17719791 [Abstract] [Full Text] [Related]
26. In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures. Kuriyama C, Kamiyama O, Ikeda K, Sanae F, Kato A, Adachi I, Imahori T, Takahata H, Okamoto T, Asano N. Bioorg Med Chem; 2008 Aug 01; 16(15):7330-6. PubMed ID: 18595718 [Abstract] [Full Text] [Related]
27. Glycogen is a preferred glutamate precursor during learning in 1-day-old chick: biochemical and behavioral evidence. Gibbs ME, Lloyd HG, Santa T, Hertz L. J Neurosci Res; 2007 Nov 15; 85(15):3326-33. PubMed ID: 17455305 [Abstract] [Full Text] [Related]
28. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase. Watson KA, Chrysina ED, Tsitsanou KE, Zographos SE, Archontis G, Fleet GW, Oikonomakos NG. Proteins; 2005 Dec 01; 61(4):966-83. PubMed ID: 16222658 [Abstract] [Full Text] [Related]
29. Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme. Freeman S, Bartlett JB, Convey G, Hardern I, Teague JL, Loxham SJ, Allen JM, Poucher SM, Charles AD. Br J Pharmacol; 2006 Nov 01; 149(6):775-85. PubMed ID: 17016495 [Abstract] [Full Text] [Related]
30. Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a. Onda K, Suzuki T, Shiraki R, Yonetoku Y, Negoro K, Momose K, Katayama N, Orita M, Yamaguchi T, Ohta M, Tsukamoto S. Bioorg Med Chem; 2008 May 15; 16(10):5452-64. PubMed ID: 18434170 [Abstract] [Full Text] [Related]
31. Inhibition of glycogen phosphorylase (GP) by CP-91,149 induces growth inhibition correlating with brain GP expression. Schnier JB, Nishi K, Monks A, Gorin FA, Bradbury EM. Biochem Biophys Res Commun; 2003 Sep 12; 309(1):126-34. PubMed ID: 12943673 [Abstract] [Full Text] [Related]
32. The effect of caffeine and caffeine analogs on rat liver phosphorylase a activity. Ercan-Fang N, Nuttall FQ. J Pharmacol Exp Ther; 1997 Mar 12; 280(3):1312-8. PubMed ID: 9067318 [Abstract] [Full Text] [Related]
33. Robust glycogen shunt activity in astrocytes: Effects of glutamatergic and adrenergic agents. Walls AB, Heimbürger CM, Bouman SD, Schousboe A, Waagepetersen HS. Neuroscience; 2009 Jan 12; 158(1):284-92. PubMed ID: 19000744 [Abstract] [Full Text] [Related]
34. Hepatic glycogen breakdown is implicated in the maintenance of plasma mannose concentration. Taguchi T, Yamashita E, Mizutani T, Nakajima H, Yabuuchi M, Asano N, Miwa I. Am J Physiol Endocrinol Metab; 2005 Mar 12; 288(3):E534-40. PubMed ID: 15536204 [Abstract] [Full Text] [Related]
36. Crystallographic studies on two bioisosteric analogues, N-acetyl-beta-D-glucopyranosylamine and N-trifluoroacetyl-beta-D-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase. Anagnostou E, Kosmopoulou MN, Chrysina ED, Leonidas DD, Hadjiloi T, Tiraidis C, Zographos SE, Györgydeák Z, Somsák L, Docsa T, Gergely P, Kolisis FN, Oikonomakos NG. Bioorg Med Chem; 2006 Jan 01; 14(1):181-9. PubMed ID: 16213146 [Abstract] [Full Text] [Related]
37. Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model. Fosgerau K, Mittelman SD, Sunehag A, Dea MK, Lundgren K, Bergman RN. Am J Physiol Endocrinol Metab; 2001 Aug 01; 281(2):E375-83. PubMed ID: 11440915 [Abstract] [Full Text] [Related]